Rokson Pharmaceuticals Private Limited

Rokson Pharmaceuticals Private Limited - healthcare in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2011PTC213998 Incorporated 24 February 2011 ROC Nagpur HQ Nagpur, Maharashtra, India
Pending Strike Off Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹2 Lakh
▲ 300% YoY
Net profit · FY 2024
₹1.63 Lakh
Net margin 81.4%
EBITDA · FY 2024
₹1.66 Lakh
EBITDA margin 82.8%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
GST registrations
2
None active

About Rokson Pharmaceuticals Private Limited

Data last updated:

Rokson Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 24 February 2011.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2011PTC213998. The company has 2 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam Sunil Mishra and Sunil Shatrughan Mishra.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.

As per the financials filed for FY 2024, the company reported a revenue of ₹2 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.63 Lakh (net margin 81.4%) and EBITDA of ₹1.66 Lakh (EBITDA margin 82.8%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years and 54% over five years.

Company details

CIN U24230MH2011PTC213998
Registration Number 213998
Incorporation Date 24 February 2011
ROC Nagpur
Listing Status Unlisted
Company Status Under Process of Striking Off
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

Contact details

Rokson Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Rokson Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Rokson Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Rokson Pharmaceuticals Private Limited

FY 2024 filings available

Rokson Pharmaceuticals Private Limited reported revenue of ₹2 Lakh (up 300% YoY) for FY 2024.

Revenue · FY 2024
₹2 Lakh ▲ 300%
Net profit · FY 2024
₹1.63 Lakh margin 81.4%
EBITDA · FY 2024
₹1.66 Lakh margin 82.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 300%
3 years · compounded
▲ 102%
5 years · compounded
▲ 54%
EBITDA CAGR growth
1 year
▲ 436%
3 years · compounded
▲ 32%
5 years · compounded
▲ 26%

Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 300% growth in the latest year. EBITDA rose 436% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.66 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.63 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin82.8%
Net Profit Margin81.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rokson Pharmaceuticals Private Limited, buy the company report.

Board of directors of Rokson Pharmaceuticals Private Limited

Rokson Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Poonam Sunil MishraDirector24 Feb 201115 Years 7 MonthsCurrent
Sunil Shatrughan MishraDirector24 Feb 201115 Years 7 MonthsCurrent

Auditor

Rokson Pharmaceuticals Private Limited is audited by AMIT R SURANA & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
AMIT R SURANA & COFY 2020127396W

Shareholding

The shareholding of Rokson Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rokson Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rokson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rokson Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of Rokson Pharmaceuticals Private Limited, buy the company report.

Recent activity

Rokson Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Sangit Ashokrao Chauhan ceased to be Director on 09 Apr 2019.

AGM
Rokson Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Rokson Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Nagpur.
Ceased
Sangit Ashokrao Chauhan ceased to be Director.
Ceased
Satendra Yagayanand Singh ceased to be Director.
Appointed
Poonam Sunil Mishra was appointed as Director.
Appointed
Sunil Shatrughan Mishra was appointed as Director.
Incorporation
24 Feb 2011
Rokson Pharmaceuticals Private Limited was registered on 24 Feb 2011 with Roc Nagpur & aged 15 years 7 months as per MCA records.

Frequently asked questions

Rokson Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.

Rokson Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Nagpur, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 24 February 2011 and is registered under CIN U24230MH2011PTC213998. The company may be struck off soon - caution is advised.

The compliance status of Rokson Pharmaceuticals is compliant as of 14 July 2026.

Rokson Pharmaceuticals has 2 current directors:

The CIN (Corporate Identification Number) of Rokson Pharmaceuticals is U24230MH2011PTC213998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rokson Pharmaceuticals was incorporated on 24 February 2011. It is registered with the Registrar of Companies, Nagpur.

The registered office of Rokson Pharmaceuticals is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.

The latest financial statements of Rokson Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

No. Rokson Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.

Rokson Pharmaceuticals operates in the healthcare industry, in the ayurvedic products and services segment.